Bank Of America Corp Mersana Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 990,036 shares of MRSN stock, worth $524,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares

990,036

Previous 159,773 519.65%

Holding current value

$524,719

Previous $321,000 482.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $1.02 Million - $1.87 Million	830,263 Added 519.65%	990,036 $1.87 Million
Q2 2024 Aug 14, 2024	SELL	$2.0 - $4.45 $99,580 - $221,565	-49,790 Reduced 23.76%	159,773 $321,000
Q1 2024 May 15, 2024	BUY	$2.16 - $5.94 $102,597 - $282,144	47,499 Added 29.31%	209,563 $938,000
Q4 2023 Feb 14, 2024	SELL	$1.11 - $2.34 $154,766 - $326,263	-139,429 Reduced 46.25%	162,064 $375,000
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $2.2 Million - $6.82 Million	-714,391 Reduced 70.32%	301,493 $991,000
Q1 2023 May 12, 2023	BUY	$4.0 - $7.02 $1.02 Million - $1.79 Million	255,161 Added 33.54%	1,015,884 $4.18 Million
Q4 2022 Feb 10, 2023	BUY	$5.65 - $7.86 $2.05 Million - $2.85 Million	363,077 Added 91.31%	760,723 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $1.58 Million - $2.73 Million	340,869 Added 600.36%	397,646 $2.69 Million
Q2 2022 Aug 12, 2022	BUY	$2.84 - $5.0 $63,252 - $111,360	22,272 Added 64.55%	56,777 $262,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $31,199 - $55,307	-8,342 Reduced 19.47%	34,505 $138,000
Q4 2021 Feb 08, 2022	SELL	$5.48 - $9.86 $189,268 - $340,544	-34,538 Reduced 44.63%	42,847 $266,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $189,629 - $320,553	22,153 Added 40.11%	77,385 $730,000
Q2 2021 Sep 13, 2021	BUY	$13.28 - $18.07 $733,480 - $998,042	55,232 New	55,232 $750,000

Others Institutions Holding MRSN

# of Institutions

123

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $51.5M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Mersana Therapeutics, Inc. Transaction History